64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2026) 8 - 10 September 2026

Four-year efficacy and safety of somapacitan treatment in children with growth hormone deficiency (GHD): results from the REAL 4 trial

Authors :

Bradley S. Miller¹, Jo Blair², Michael Højby³, Jan Frystyk^4,5, Aristides Maniatis⁶, Tina Lund Leunbach³, Jun Mori⁷, Jin-Ho Choi⁸, Volker Böttcher⁹, Michel Polak¹⁰

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Rare Endocrine Disorder

Congress poster

Somapacitan

Search Science Hub

Are you a healthcare professional?

Four-year efficacy and safety of somapacitan treatment in children with growth hormone deficiency (GHD): results from the REAL 4 trial